Diagnosis of early atherosclerotic lesions, and selected atherosclerotic risk factors, in patients with systemic lupus erythematosus

被引:8
作者
Fischer, Katarzyna [1 ]
Brzosko, Marek [1 ]
机构
[1] Pomeranian Med Univ, Dept Rheumatol & Internal Dis, Szczecin, Poland
来源
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2009年 / 119卷 / 11期
关键词
antiphospholipid syndrome; atherosclerosis; imaging study; risk factors; systemic lupus erythematosus; PRIMARY ANTIPHOSPHOLIPID SYNDROME; INTIMA-MEDIA THICKNESS; PERIPHERAL VASCULAR-DISEASE; CORONARY-ARTERY-DISEASE; ANKLE-BRACHIAL INDEX; LOW-DENSITY-LIPOPROTEIN; HUMAN ENDOTHELIAL-CELLS; PULSE-WAVE VELOCITY; PREMATURE ATHEROSCLEROSIS; CAROTID PLAQUE;
D O I
10.20452/pamw.827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Early diagnosis of subclinical atherosclerosis can be established using noninvasive imaging techniques, which enable to assess atherosclerotic lesions at different stages of their development, from endothelial dysfunction, through morphological lesions in the arteries, to advanced atherosclerotic plaques. Given high risk of accelerated development of atherosclerotic lesions in patients with systemic lupus erythematosus (SLE), these techniques should be incorporated in routine diagnostic evaluation in this population. Cardiovascular risk factors in patients with SLE differ significantly from those observed in the general population. Chronic inflammation and the presence of autoantibodies play the key role, while classic risk factors are less important. Subclinical atherosclerotic lesions can be detected in 30% to 40% of the SLE patients. The occurrence of severe symptoms in the cardiovascular and central nervous systems can be caused by such lesions. Recent data indicate that the main causes of death in this patient group represent cardiovascular complications. Early identification of patients in the risk group allows to implement appropriate prophylactic and therapeutic procedures.
引用
收藏
页码:736 / 742
页数:7
相关论文
共 50 条
  • [41] Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus
    Driest, K. D.
    Sturm, M. S.
    O'Brien, S. H.
    Spencer, C. H.
    Stanek, J. R.
    Ardoin, S. P.
    LUPUS, 2016, 25 (07) : 749 - 753
  • [42] Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort
    Urowitz, Murray B.
    Gladman, Dafna D.
    Farewell, Vernon
    Su, Jiandong
    Romero-Diaz, Juanita
    Bae, Sang-Cheol
    Fortin, Paul R.
    Sanchez-Guerrero, Jorge
    Clarke, Ann Elaine
    Bernatsky, Sasha
    Gordon, Caroline
    Hanly, John G.
    Wallace, Daniel J.
    Isenberg, David A.
    Rahman, Anisur
    Merrill, Joan T.
    Ginzler, Ellen
    Alarcon, Graciela S.
    Chatham, W. Winn
    Petri, Michelle A.
    Bruce, Ian N.
    Khamashta, Munther A.
    Aranow, Cynthia
    Dooley, Mary Anne
    Manzi, Susan
    Ramsey-Goldman, Rosalind
    Nived, Ola
    Joensen, Andreas
    Steinsson, Kristjan
    Zoma, Asad A.
    Ruiz-Irastorza, Guillermo
    Lim, S. Sam
    Kalunian, Kenneth C.
    Inanc, Murat
    van Vollenhoven, Ronald
    Ramos-Casals, Manuel
    Kamen, Diane L.
    Jacobsen, Soren
    Peschken, Christine A.
    Askanase, Anca
    Stoll, Thomas
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (10) : 1734 - 1740
  • [43] Cardiovascular risk assessment and treatment in systemic lupus erythematosus
    Elliott, Jennifer R.
    Manzi, Susan
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2009, 23 (04): : 481 - 494
  • [44] Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand
    Juthong, Siriporn
    Geater, Alan F.
    Dekumyoy, Paron
    Hortiwakul, Thanaporn
    Siripaitoon, Boonjing
    Aiewruengsurat, Duangkamol
    Thongbun, Nannapas
    LUPUS, 2020, 29 (06) : 539 - 546
  • [45] Clinical characteristics and risk factors of cardiovascular disease in systemic lupus erythematosus patients
    Liao, Qiumei
    Zhong, Yeping
    Cheng, Yalin
    Li, Xiuxiu
    HEART AND VESSELS, 2024,
  • [46] Soluble CD40 ligand in systemic lupus erythematosus: Link with atherosclerotic vascular affection
    Popkova, T., V
    Panafidina, T. A.
    Alexandrova, E. N.
    Novikova, D. S.
    Novikov, A. A.
    Alekberova, Z. S.
    Mach, E. S.
    Nasonov, E. L.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (05) : 37 - 41
  • [47] Risk factors of disease activity and renal damage in patients with systemic lupus erythematosus
    Feng, Huiling
    Lu, Qianyu
    Liu, Yi
    Shi, Mengmeng
    Lian, Huan
    Ni, Lihua
    Wu, Xiaoyan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (12) : 3845 - 3855
  • [48] Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis
    Wu, Guo-Cui
    Liu, Hai-Rong
    Leng, Rui-Xue
    Li, Xiang-Pei
    Li, Xiao-Mei
    Pan, Hai-Feng
    Ye, Dong-Qing
    AUTOIMMUNITY REVIEWS, 2016, 15 (01) : 22 - 37
  • [49] IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors
    Sun, Jitong
    Lundstrom, Susanna L.
    Zhang, Bo
    Zubarev, Roman A.
    Steuer, Johnny
    Gillgren, Peter
    Rahman, Mizanur
    Ajeganova, Sofia
    Liu, Anquan
    Frostegard, Johan
    ATHEROSCLEROSIS, 2018, 268 : 36 - 48
  • [50] Heart valve calcification in young patients with systemic lupus erythematosus: A window to premature atherosclerotic vascular morbidity and a risk factor for all-cause mortality
    Molad, Y
    Levin-Laina, N
    Vaturi, M
    Sulkes, J
    Sagie, A
    ATHEROSCLEROSIS, 2006, 185 (02) : 406 - 412